{
    "organizations": [],
    "uuid": "5c84bbba6f98d90352d872fd1e8072bd32795768",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-wolwo-bio-pharmaceutical/brief-zhejiang-wolwo-bio-pharmaceutical-sees-fy-2017-net-profit-up-40-pct-to-50-pct-idUSL4N1P61OI",
    "ord_in_thread": 0,
    "title": "BRIEF-Zhejiang Wolwo Bio-Pharmaceutical sees FY 2017 net profit up 40 pct to 50 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 11 (Reuters) - Zhejiang Wolwo Bio-Pharmaceutical Co Ltd\n* Says it sees net profit for FY 2017 to increase by 40 percent to 50 percent, or to be 180.9 million yuan to 193.8 million yuan\n* Says the net profit of FY 2016 was 129.2 million yuan\n* Comments that increased business income and decreased costs as main reasons for the forecast\nSource text in Chinese: goo.gl/VZ3bvz\nFurther company coverage: (Beijing Headline News)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-11T11:15:00.000+02:00",
    "crawled": "2018-01-11T12:17:34.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "zhejiang",
        "wolwo",
        "co",
        "ltd",
        "say",
        "see",
        "net",
        "profit",
        "fy",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "net",
        "profit",
        "fy",
        "million",
        "yuan",
        "comment",
        "increased",
        "business",
        "income",
        "decreased",
        "cost",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}